3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Rhabdomyosarcoma
5
Wilms Tumor
4
Sarcoma
4
Hydatidiform Mole
2
Rhabdomyosarcoma, Embryonal
1
Rhabdomyosarcoma, Alveolar
1
Rhabdoid Tumor
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Melanoma
1
Malignant mesenchymal tumor
1
Lymphoma
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia
1
Fibrosarcoma
1
Choroid Plexus Neoplasms
1
Choriocarcinoma
1
Central Nervous System Neoplasms
1
Carcinoma, Renal Cell
1
Brain Neoplasms
1
Blast Crisis
1
Beckwith-Wiedemann Syndrome
1
Interventions
Ifosfamide
6
X-Rays
5
Phantoms, Imaging
5
Magnetic Resonance Spectroscopy
5
Filgrastim
5
Etoposide
5
Doxorubicin
5
Cyclophosphamide
5
Vincristine
4
Temozolomide
4
Specimen Handling
4
Radiotherapy
4
Nuclear Medicine Department, Hospital
4
Melphalan
4
Thiotepa
3
Irinotecan
3
Biopsy
3
Bevacizumab
3
ulixertinib
2
trioctyl phosphine oxide
2
tipifarnib
2
temsirolimus
2
tazemetostat
2
selpercatinib
2
palbociclib
2
olaparib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
cixutumumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Neuroectodermal Tumors, Primitive, Peripheral
×
Dactinomycin
×
Clear all
No trials found.